JPRN-UMIN000000545
Completed
Phase 2
Phase II study of reduced-dose craniospinal irradiation and combination chemotherapy in treating pediatric patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumors - Reduced-dose radiation plus chemotherapy in treating pediatric patients with medulloblastoma/sPNET
Japanese Pediatric Brain Tumor Consortium0 sites100 target enrollmentDecember 8, 2006
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- medulloblastoma or supratentorial primitive neuroectodermal tumors
- Sponsor
- Japanese Pediatric Brain Tumor Consortium
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Has double cancer. Has cardiac disease for which treatment is necessary.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 2
Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven MedulloblastomaMedulloblastomaNCT02724579Children's Oncology Group45
Recruiting
Phase 2
Focal Radiation and low dose skull and spine irradiation followed by chemotherapy for WNT subgroup medulloblastomaCTRI/2020/08/027117Tata Memorial Hospital
Unknown
Phase 2
High-dose Chemotherapy With Autologous Stem Cell Rescue in Pediatric High-risk Brain TumorsBrain TumorNCT00798811Samsung Medical Center100
Terminated
Not Applicable
Low Dose RT to Reduce Cerebral Amyloidosis in Early Alzheimer'sAlzheimer's DiseaseNCT02769000Virginia Commonwealth University5
Active, not recruiting
Phase 2
Proton Craniospinal Radiation Therapy vs. Partial Photon Radiation Therapy for Leptomeningeal Metastasis From Solid TumorsLeptomeningeal MetastasesNCT04343573Memorial Sloan Kettering Cancer Center102